The IPSS-R has prognostic impact in untreated patients with MDS del(5q)

Kaivers, J; Lauseker, M; Hildebrandt, B; Fenaux, P; Pfeilstocker, M; Valent, P; Platzbecker, U; Latagliata, R; Oliva, EN; Xicoy, B; Gotze, K; Ganster, C; Haase, D; Bug, G; Kundgen, A; Gattermann, N; Haas, R; Germing, U

Kaivers, J (reprint author), Univ Hosp Dusseldorf, Dept Hematol Oncol & Clin Immunol, Moorenstr 5, D-40225 Dusseldorf, Germany.

LEUKEMIA RESEARCH, 2018; 72 (): 27

Abstract

The IPSS-R proved to be a powerful tool for the assessment of prognosis in MDS patients. We aimed at a validation of the IPSS-R for patients with MDS ......

Full Text Link